Email Log
GreenLeaf Bio Q2 update
SuccessFrom priya@greenleafbio.com
Jul 21, 2026, 04:30 PM
Company: GreenLeaf Bio
Metrics Written (4)
| Metric | Period | Value | Confidence |
|---|---|---|---|
| Cash on Hand | Q1 2026 | $1200000 | high |
| Cash on Hand | Q2 2026 | $950000 | high |
| Headcount | Q1 2026 | 14 | high |
| Headcount | Q2 2026 | 15 | high |
Metrics
2 configuredCash on Hand($)Headcount
Email body
Dear investors, Plainly: the EPA has asked for an additional field season of data, so approval moves from Q2 2026 to the second half of 2027. Pilot revenue is unchanged. Cash was $950K at the end of June, about five months of runway. We are raising a bridge and have $600K of soft commitments; we would welcome the fund's participation. Headcount is 15. Priya
Upload document
If the report was linked rather than attached, upload it here so it can be processed with the email.
Process or skip
Choose the destination yourself, let classification decide, or intentionally skip the email. An explicit destination will not be overridden by classification.